Table 1 Characteristics of dialysis incident patients in mainland France in 2012, according to the dialysis initiation condition: planned start or emergency start
From: Deleterious effects of dialysis emergency start, insights from the French REIN registry
Planned start (n = 6161; 69.7%) | Emergency start (n = 2678; 30.3%) | ||
|---|---|---|---|
n (%) | n (%) | p | |
Men | 3918 (63.6) | 1736 (64.8) | 0.268 |
Age, y (mean ± SD) | 67.9 ± 18.8 | 67.8 ± 16.4 | 0.65 |
Primary renal disease | < 0.001 | ||
Acute nephropathy | 478 (7.8) | 407 (15.2) | |
Slowly progressive nephropathy | 4454 (72.3) | 1668 (62.3) | |
Unknown | 1229 (19.9) | 603 (22.5) | |
Serum albumin < 30 g/dl | 981 (15.9) | 669 (25) | < 0.001 |
Missing | 1090 (17.7) | 563 (21) | |
BMI (kg/m2) | < 0.001 | ||
< 18.5 | 254 (4.1) | 158 (5.9) | |
18.5–25 | 1908 (31) | 865 (32.3) | |
> 25 | 2658 (43.1) | 987 (36.9) | |
Missing | 1341 (21.8) | 668 (24.9) | |
Smoking status | 0.006 | ||
Current smoker | 594 (9.6) | 277 (10.3) | |
Former smoker | 1464 (23.8) | 658 (24.6) | |
Never smoker | 3209 (52.1) | 1237 (46.2) | |
Missing | 894 (14.5) | 506 (18.9) | |
Respiratory disease | 725 (11.8) | 457 (17.1) | < 0.001 |
Hepatic disease | 127 (2.1) | 80 (3) | 0.005 |
Active malignancya | 636 (10.3) | 394 (14.7) | < 0.001 |
Diabetes | 2459 (39.9) | 1105 (41.3) | 0.229 |
Type 1 | 162 (6.6) | 47 (4.3) | 0.006 |
Type 2 | 2280 (92.7) | 1051 (95.1) | |
Cardiovascular diseasesb | < 0.001 | ||
0 | 2995 (48.6) | 1055 (39.4) | |
1 | 1390 (22.6) | 573 (21.4) | |
2 | 895 (14.5) | 479 (17.9) | |
≥ 3 | 881 (14.3) | 571 (21.3) | |
Mobility | < 0.001 | ||
Totally dependent for transfers | 216 (3.5) | 209 (7.8) | |
Need assistance for transfers | 638 (10.4) | 407 (15.2) | |
Walk without help | 4718 (76.6) | 1760 (65.7) | |
First dialysis modality | < 0.001 | ||
HD/HDF | 5333 (86.6) | 2628 (98.2) | |
APD/CAPD | 828 (13.4) | 49 (1.8) | |
Vascular access at initiation | |||
Central venous catheter | 2115 (34.3) | 2286 (85.4) | < 0.001 |
Arteriovenous fistula (used or not) | 3291 (53.4) | 566 (21.1) | < 0.001 |
Pre-dialysis anemia management | |||
Hemoglobin < 10 g/dl | 2660 (43.2) | 1628 (60.8) | < 0.001 |
ESA therapy | 2860 (46.4) | 709 (26.5) | < 0.001 |
Residual eGFR ml/min/1.73m2 (median, IQR) | 9.2 (7.2–12.1) | 8.05 (5.5–11.4) | < 0.001 |
Missing | 725 (11.8) | 355 (13.3) | |
Waitlisted at dialysis initiation (< 80 years) | 580 (12.1) | 37 (1.8) | < 0.001 |